How many claudicants should be prescribed statins?

European Journal of Vascular and Endovascular Surgery

Volumn 25, Issue 4, 2003, Pages 367-368

  Harrison, E M ^a   Holdsworth, R J ^a  

^a Stirling Royal Infirmary   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; LEG ANGIOGRAPHY; PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0038076127     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1813     Document Type: Article

References (7)

1. SHEPHERD J, COBBE SM, FORD I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995; 333: 1301-1307.
2. SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383-1389.
3. LENG GC, PRICE JF, JEPSON RG. Lipid-lowering for lower limb atherosclerosis (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.
4. LENG GC, FOWKES FGR. The epidemiology of peripheral arterial disease. Vasc Med Rev 1993; 4: 5-18.
5. WINYARD G. Standing Medical Advisory Committee Statement on the Use of Statins. London: Department of Health, 1997. (EL(97)41HC-D7501P, Aug 1997.)
6. SCOTTISH INTERCOLLEGIATE GUIDELINES NETWORK. Lipids and primary prevention of coronary heart disease. In: Edinburgh: Royal College of Physicians, 1999. (SIGN publication No 40.)
7. DOWNS JR, CLEARFIELD M, WEIS S et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 79: 1615-1622.